Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C26H25NO4 |
| Molecular Weight | 415.481 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(OC)C=C2C=C(C(=O)OC2=C1)C3=CC=C(CN(C)CC4=CC=CC=C4)C=C3
InChI
InChIKey=KXMCSAUVAHKCOR-UHFFFAOYSA-N
InChI=1S/C26H25NO4/c1-27(16-18-7-5-4-6-8-18)17-19-9-11-20(12-10-19)22-13-21-14-24(29-2)25(30-3)15-23(21)31-26(22)28/h4-15H,16-17H2,1-3H3
| Molecular Formula | C26H25NO4 |
| Molecular Weight | 415.481 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy. | 2003 Jun 5 |
|
| Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives. | 2007 Aug 23 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:04:32 GMT 2023
by
admin
on
Sat Dec 16 10:04:32 GMT 2023
|
| Record UNII |
545225E0BC
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9844749
Created by
admin on Sat Dec 16 10:04:32 GMT 2023 , Edited by admin on Sat Dec 16 10:04:32 GMT 2023
|
PRIMARY | |||
|
553681-56-4
Created by
admin on Sat Dec 16 10:04:32 GMT 2023 , Edited by admin on Sat Dec 16 10:04:32 GMT 2023
|
PRIMARY | |||
|
545225E0BC
Created by
admin on Sat Dec 16 10:04:32 GMT 2023 , Edited by admin on Sat Dec 16 10:04:32 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
